217 related articles for article (PubMed ID: 38082435)
1. Microbiota: A key factor affecting and regulating the efficacy of immunotherapy.
Jiang Y; Jia D; Sun Y; Ding N; Wang L
Clin Transl Med; 2023 Dec; 13(12):e1508. PubMed ID: 38082435
[TBL] [Abstract][Full Text] [Related]
2. Critical role of the gut microbiota in immune responses and cancer immunotherapy.
Li Z; Xiong W; Liang Z; Wang J; Zeng Z; Kołat D; Li X; Zhou D; Xu X; Zhao L
J Hematol Oncol; 2024 May; 17(1):33. PubMed ID: 38745196
[TBL] [Abstract][Full Text] [Related]
3. Fecal microbiota transplantation: no longer cinderella in tumour immunotherapy.
Yang Y; An Y; Dong Y; Chu Q; Wei J; Wang B; Cao H
EBioMedicine; 2024 Feb; 100():104967. PubMed ID: 38241975
[TBL] [Abstract][Full Text] [Related]
4. Modulatory effects of gut microbiome in cancer immunotherapy: A novel paradigm for blockade of immune checkpoint inhibitors.
Rezasoltani S; Yadegar A; Asadzadeh Aghdaei H; Reza Zali M
Cancer Med; 2021 Feb; 10(3):1141-1154. PubMed ID: 33369247
[TBL] [Abstract][Full Text] [Related]
5. Emerging role of microbiota in immunomodulation and cancer immunotherapy.
Singh RP; Bashir H; Kumar R
Semin Cancer Biol; 2021 May; 70():37-52. PubMed ID: 32580024
[TBL] [Abstract][Full Text] [Related]
6. Cancer and the Microbiome-Influence of the Commensal Microbiota on Cancer, Immune Responses, and Immunotherapy.
Matson V; Chervin CS; Gajewski TF
Gastroenterology; 2021 Jan; 160(2):600-613. PubMed ID: 33253684
[TBL] [Abstract][Full Text] [Related]
7. Impact of gut microbiome in the development and treatment of pancreatic cancer: Newer insights.
Bangolo AI; Trivedi C; Jani I; Pender S; Khalid H; Alqinai B; Intisar A; Randhawa K; Moore J; De Deugd N; Faisal S; Suresh SB; Gopani P; Nagesh VK; Proverbs-Singh T; Weissman S
World J Gastroenterol; 2023 Jul; 29(25):3984-3998. PubMed ID: 37476590
[TBL] [Abstract][Full Text] [Related]
8. Cancer Immunotherapy: A Focus on the Regulation of Immune Checkpoints.
Shi T; Ma Y; Yu L; Jiang J; Shen S; Hou Y; Wang T
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29735917
[TBL] [Abstract][Full Text] [Related]
9. Modulation of Gut Microbiota to Enhance Effect of Checkpoint Inhibitor Immunotherapy.
Wu J; Wang S; Zheng B; Qiu X; Wang H; Chen L
Front Immunol; 2021; 12():669150. PubMed ID: 34267748
[TBL] [Abstract][Full Text] [Related]
10. Compartmentalization of the host microbiome: how tumor microbiota shapes checkpoint immunotherapy outcome and offers therapeutic prospects.
Boesch M; Horvath L; Baty F; Pircher A; Wolf D; Spahn S; Straussman R; Tilg H; Brutsche MH
J Immunother Cancer; 2022 Nov; 10(11):. PubMed ID: 36343977
[TBL] [Abstract][Full Text] [Related]
11. Effect of Gut Microbiota-Derived Metabolites on Immune Checkpoint Inhibitor Therapy: Enemy or Friend?
Zhao H; Wang D; Zhang Z; Xian J; Bai X
Molecules; 2022 Jul; 27(15):. PubMed ID: 35956752
[TBL] [Abstract][Full Text] [Related]
12. Gut microbiota interactions with antitumor immunity in colorectal cancer: From understanding to application.
Zhuang YP; Zhou HL; Chen HB; Zheng MY; Liang YW; Gu YT; Li WT; Qiu WL; Zhou HG
Biomed Pharmacother; 2023 Sep; 165():115040. PubMed ID: 37364479
[TBL] [Abstract][Full Text] [Related]
13. Gut microbiota and tumor-associated macrophages: potential in tumor diagnosis and treatment.
Zhou D; Li Y
Gut Microbes; 2023 Dec; 15(2):2276314. PubMed ID: 37943609
[TBL] [Abstract][Full Text] [Related]
14. Exploring the Emerging Role of the Gut Microbiota and Tumor Microenvironment in Cancer Immunotherapy.
Qiu Q; Lin Y; Ma Y; Li X; Liang J; Chen Z; Liu K; Huang Y; Luo H; Huang R; Luo L
Front Immunol; 2020; 11():612202. PubMed ID: 33488618
[TBL] [Abstract][Full Text] [Related]
15. Targeted modulation of gut and intra-tumor microbiota to improve the quality of immune checkpoint inhibitor responses.
Wang W; Fan J; Zhang C; Huang Y; Chen Y; Fu S; Wu J
Microbiol Res; 2024 May; 282():127668. PubMed ID: 38430889
[TBL] [Abstract][Full Text] [Related]
16. Gut microbiota influence immunotherapy responses: mechanisms and therapeutic strategies.
Lu Y; Yuan X; Wang M; He Z; Li H; Wang J; Li Q
J Hematol Oncol; 2022 Apr; 15(1):47. PubMed ID: 35488243
[TBL] [Abstract][Full Text] [Related]
17. Emerging roles of the gut microbiota in cancer immunotherapy.
Shi Z; Li H; Song W; Zhou Z; Li Z; Zhang M
Front Immunol; 2023; 14():1139821. PubMed ID: 36911704
[TBL] [Abstract][Full Text] [Related]
18. The role of the gut microbiota in gastric cancer: the immunoregulation and immunotherapy.
Wang M; Yang G; Tian Y; Zhang Q; Liu Z; Xin Y
Front Immunol; 2023; 14():1183331. PubMed ID: 37457738
[TBL] [Abstract][Full Text] [Related]
19. Exploring the emerging role of the microbiome in cancer immunotherapy.
Fessler J; Matson V; Gajewski TF
J Immunother Cancer; 2019 Apr; 7(1):108. PubMed ID: 30995949
[TBL] [Abstract][Full Text] [Related]
20. The Role of Gut Microbiota in Tumor Immunotherapy.
Wu M; Bai J; Ma C; Wei J; Du X
J Immunol Res; 2021; 2021():5061570. PubMed ID: 34485534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
